InterveXion Therapeutics

October 12, 2017

Researchers Awarded $8 Million for Anti-Methamphetamine Medication Study

Ben Boulden

Oct. 12, 2017 | Led by UAMS researchers, a new clinical study  called STAMPOUT aims to help a drug user stay in treatment by keeping the effects of the drug from going into the brain. This month, the National Institutes of Health (NIH) National Institute on Drug Abuse awarded the InterveXion/UAMS research team an $8…

December 11, 2015

Michael Owens, Ph.D., Named Arkansas Research Alliance Fellow

Yavonda Chase

Dec. 11, 2015 | The Arkansas Research Alliance named UAMS’ Michael Owens, Ph.D., an ARA Fellow during a news conference Dec. 10 at the state Capitol. Owens, who has spent more than 30 years researching the development of medicines to treat drug abuse, particularly methamphetamine, was one of five Fellows presented by Gov. Asa Hutchinson….

January 29, 2015

UAMS Startup Gets $14.5 Million to Develop Drug Therapies for Methamphetamine Users

Spencer Watson

January 29, 2015 | A University of Arkansas for Medical Sciences (UAMS) BioVentures startup company, InterveXion Therapeutics LLC, has received two federal grants totaling $14.5 million for development of drug therapies that can help methamphetamine drug abusers break their addiction.